SUBMISSION EXTENDED UNTIL MONDAY 31 AUGUST

If you experience issues submitting your abstract, please ensure your browser is up to date, or change your browser. Compatible browsers include Google Chrome, Safari, Internet Explorer 10, Mozilla Firefox and Microsoft Edge.
Microsoft Edge is the preferred browser to use on Queensland Health computers.

Partnering Into The Future: Looking Up, Reaching Out

Date: 7-11 December 2020

Venue: Education Centre, Royal Brisbane and Women’s Hospital

The Royal Brisbane and Women’s Hospital and Herston Partners will host the Herston Health Precinct Symposium, showcasing the precinct’s clinical strengths, research and innovation, fostering partnerships and reinforcing the commitment to provide a wealth of opportunities for Healthcare providers.
The Symposium offers an opportunity to join colleagues and to be informed on national and international best practice and innovative healthcare.

Call for abstracts

The 2020 Organising Committee is currently calling for abstract submissions from RBWH Researchers and Herston Partner Organisations for research related to the provision of healthcare.

Submissions close ~~Sunday 23 August~~ Extended to Monday 31 August!

Abstract submissions should be no more than 300 words in length including heading, authors and content, and will only be accepted in Word or PDF format (.doc, .docx or .pdf). Please include the following (an example is provided):

Sentence stating the purpose of the study
Brief description of the methods
Statement of results
Statement of conclusions

Categories of Research include:

Discovery and Innovation: Research which is based on innovation, technology (including information technology and biotechnology) and/or basic science which is relevant to improving clinical health care

Clinical Research: Research conducted to explore new ways of delivering improved health care services

Translational Research: Research that demonstrates the implementation of evidence-based practices that deliver improved patient and healthcare outcomes

All abstracts will be reviewed prior to acceptance and successful applicants will be informed by September 30 2020.

ePosters

All accepted abstracts will be displayed as posters on the Symposium website and open to questions via email (or other electronic means). If accepted, you will be provided detailed submission instructions and a PowerPoint template for your poster.

Orals

There will be two types of oral sessions – one open to all research abstracts, and one specifically for those undertaking a Higher Research Degree and junior medical officers applying for or currently on a training program.

A limited number of abstracts will be accepted for oral presentations. Presentation time will be strictly five minutes in total, a three-minute presentation followed by two minutes of question time. This will be pre-recorded and run through ZOOM. You will be provided with further details should you be selected.

Awards

The presentation judged to be of the highest standard in the following categories will each be awarded $1000 (provided from the RBWH Foundation) towards attendance at a relevant national or international conference. Awards are open to individuals or teams based at the Herston campus.

Discovery and Innovation Research Award

Open to all researchers
Best research oral or poster presentation that addresses research which is based on innovation, technology (including information technology and biotechnology) and/or basic science which is relevant to improving clinical health care

The Dr Stephen Morrison Clinical Research Award

Open to all researchers
Best research oral or poster presentation that addresses research conducted to explore new ways of delivering improved health care services

Translational Research Award

Open to all researchers
Best research oral or poster presentation that demonstrates the implementation of evidence-based research that improves patient and healthcare outcomes

Professor Lawrie Powell AC Early Career Research Award

Best research oral or poster presentation by an individual currently enrolled in a research higher degree

The Professor William Egerton Award for Medical Research

Best research oral or poster presentation by a junior medical practitioner researcher
Open to medically-qualified practitioners (e.g. registrars or junior consultants)

The Award for Nursing Research

Best research oral or poster presentation by a nurse researcher
Open to nurse-qualified practitioners

The Award for Health Practitioner Research – co-sponsored by RBWH Foundation and the Collaborative for Allied Health Research Learning and Innovation (CAHRLI)

Best research oral or poster presentation by a health practitioner researcher
Open to health practitioner qualified practitioners (i.e. Allied Health Practitioner/Scientist)

Example Abstract

Penicillin allergy need not be forever

Jenna Turkington1, Alice Young2, Andrew Redmond2. 1.RBWH Pharmacy Dept 2. Infectious Diseases RBWH

Purpose: Antibiotic allergy labels (AAL) are associated with increased in-hospital mortality, length of stay and healthcare costs. To combat this an outpatient clinic to review penicillin allergy and delabel patients no longer allergic was established.

Methods: With funding from a MNHHS Seed grant a weekly multidisciplinary outpatient clinic dedicated to assessment of patients with penicillin allergies was developed with a dedicated pharmacist, infectious diseases physician and clinical nurse. Members of the team underwent training at the Antibiotic Allergy in Practice Workshop at Austin Health. A procedure was developed, with the pharmacist taking a medication and allergy history and with the physician developing a plan for testing (skin prick, intradermal and oral provocation). The nurse performed skin and oral provocation testing and monitoring. Patients with histories suggestive of severe cutaneous adverse reactions (DRESS, SJS, TEN) or severe organ-based drug reactions (eg nephritis, hepatitis) were excluded from testing.

Results: In the first six months of operation the service assessed seventy patients and was able to delabel sixty-one (87%) from their penicillin allergy. There were very high-level patient satisfaction ratings. All delabeled patients reported they would be happy to take penicillins in the future. Of those patients who returned feedback forms (n=54) 96% were extremely likely to refer friends or family to the service and 98% of patients rated the care they received as excellent. Comments received include “staff [were] extremely informative, friendly, efficient and reassuring from the word go. A good experience” and “this is an excellent service I truly hope it expands to provide a service to many more Queenslanders”.

Conclusions: Using an evidence-based, structured risk assessment and testing of patients with penicillin AAL this allows safe use of potent, narrow spectrum antibiotics in patients who were inappropriately labelled as allergic.

Warning !!!

CSS Style is being disabled or blocked. Please enable CSS in your browser.

The Event is closed